Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This first-in-human study will be counducted to evaluate the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of YH32367 in Patients with HER2-Positive Locally Advanced or Metastatic Solid Tumors.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony nowotwór z podwyższonym poziomem białka HER2
- •Dostarczona próbka tkanki guza
- •Co najmniej jedna zmiana widoczna w badaniach obrazowych
- •Rak dróg żółciowych z podwyższonym HER2 (Grupa 1)
- •Inne zaawansowane nowotwory ze zwiększonym HER2, poza rakiem piersi i żołądka (Grupa 2)
✗ Disqualifies
- •Przerzuty do mózgu, które nie są kontrolowane
- •Uciśnięcie rdzenia kręgowego
- •Zapalenie opon mózgowych spowodowane nowotworem
- •Zawał serca lub inne ostre problemy sercowe
- •Niewydolność serca
- •Choroby śródmiąższowe płuc
- •Zapalenie płuc
- •Historia innego nowotworu złośliwego w przeszłości
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 16, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (19)
Dana Farber Cancer Institute
Boston, United States
Vanderbilt Ingram Cancer Center
Nashville, United States
Southern Oncology Clinical Research Unit
Adelaide, Australia
Austin Health
Melbourne, Australia
Breast Cancer Research Centre - WA
Perth, Australia
Blacktown Hospital
Sydney, Australia
CHA Bundang Medical Center
Seongnam-si, South Korea
Catholic University of Korea St. Vincent's Hospital
Suwon, South Korea
Ajou University Hospital
Suwon, South Korea
Gyeongsang National University Hospital
Jinju, South Korea
Chungbuk National University Hospital
Cheongju-si, South Korea
Gachon Gil University Medical Center
Incheon, South Korea
Korea University Anam Hospital
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Severance Hospital, Yonsei University Health System
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
The Catholic University of Korea, St. Mary's hospital
Seoul, South Korea
Ulsan University Hospital
Ulsan, South Korea
Trial contact
Clinical Operation Team 1
Heayeon Yoo
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.